Retatrutide is designed for subcutaneous (under skin) injection into fat tissue
Side effects The most common side effects of GLP-1 medications are gastrointestinal, and theyre directly tied to how the drugs work
Marso SP, Nauck MA, Monk Fries T, Rasmussen S, Treppendahl MB, Buse JB
With the advancement of research and technology, Retatrutide is expected to become a milestone in the treatment of metabolic diseases, opening a new chapter of healthy living for hundreds of millions of patients worldwide.
Other considerations include if this class of medications is dropped from coverage, patients on the drugs will need to find other ways to pay for it if they want to continue, the affordability and availability of the medications, and what will the long-term impact be if patients stop taking the medications suddenly
That means the peptide stays intact as it enters the system